BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3184787)

  • 1. [Isovolemic hemodilution in patients with coronary heart disease].
    Kiesewetter H; Erlenwein S; Jung F; Wenzel E; Vogel W; Dyckmans J; Bach R; Hahmann H; Schieffer H; Bette L
    Klin Wochenschr; 1988; 66 Suppl 15():8-14. PubMed ID: 3184787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isovolemic hemodilution in coronary heart disease--clinical and hemodynamic effects].
    Neubaur TE; Peters A; Schobel FC; Leschke M; Strauer BE
    Z Kardiol; 1996 Jan; 85(1):1-5. PubMed ID: 8717140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemorheologic therapy applications in coronary heart disease].
    Leschke M; Motz W; Strauer BE
    Wien Med Wochenschr; 1986; 136 Spec No():17-24. PubMed ID: 3825169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of hemodilution on systemic and capillary hematocrit].
    Jung F; Koscielny J; Mrowietz C; Wolf S; Kiesewetter H; Wenzel E
    Infusionstherapie; 1990 Oct; 17(5):268-75. PubMed ID: 1705247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From low hematocrit physiology to isovolemic hemodilution.
    Oriani G; Sacchi C; Borghi B
    Int J Artif Organs; 1995 Mar; 18(3):143-9. PubMed ID: 7499017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic infusions of middle molecular weight hydroxyethyl starch (10%, 200,000/0.62) in healthy probands].
    Scheffler P; Jung F; Mrowietz C; Waldhausen P; Leipnitz G; Häuser B
    Infusionsther Klin Ernahr; 1987 Oct; 14(5):233-8. PubMed ID: 2445681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
    Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
    Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isovolemic hemodilution: a therapeutical intervention for improving microcirculation.
    Rudofsky G
    Int Angiol; 1986; 5(3):151-4. PubMed ID: 3559316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
    Haller M; Brechtelsbauer H; Akbulut C; Fett W; Briegel J; Finsterer U
    Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isovolemic hemodilution in cerebral ischemic attack: clinical and hemorheological evaluation].
    Porro F; Curti L; Figini G; Pastori M
    Ric Clin Lab; 1989; 19 Suppl 1():113-6. PubMed ID: 2629068
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in the hemostatic system in patients with ischemic heart disease after isovolemic hemodilution].
    Liusov VA; Soboleva VN; Katyshkina NI
    Kardiologiia; 1985 Sep; 25(9):63-7. PubMed ID: 4079228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effects of acute isovolemic hemodilution in a rat model of transient coronary occlusion.
    Licker M; Mariethoz E; Costa MJ; Morel D
    Crit Care Med; 2005 Oct; 33(10):2302-8. PubMed ID: 16215385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)].
    Jung F; Waldhausen P; Spitzer S; Mrowietz C; Häuser B; Wenzel E
    Infusionstherapie; 1988 Dec; 15(6):265-71. PubMed ID: 2466797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences with the clinical use of iso- and hypervolemic hemodilution in conservative therapy of vascular diseases].
    Turowski A; Schmidt H; Sternitzky R; Brehme S; Keysser G; Hiebsch G; Hiebsch U
    Vasa Suppl; 1991; 32():338-41. PubMed ID: 1771528
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myocardial oxygen supply in hemodilution in patients with healthy hearts and heart surgery patients].
    Klövekorn WP
    Infusionstherapie; 1990 Apr; 17 Suppl 2():24-7. PubMed ID: 2197224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on isovolemic hemodilution in acute ischemic stroke.
    Comes L; Mureşan A; Costin Z
    Rom J Intern Med; 1996; 34(1-2):43-7. PubMed ID: 8908629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isovolemic hemodilution increases retinal tissue oxygen tension.
    Neely KA; Ernest JT; Goldstick TK; Linsenmeier RA; Moss J
    Graefes Arch Clin Exp Ophthalmol; 1996 Nov; 234(11):688-94. PubMed ID: 8950589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
    Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
    Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemorheological study in patients with coronary artery disease.
    Mares M; Bertolo C; Terribile V; Girolami A
    Cardiology; 1991; 78(2):111-6. PubMed ID: 2070368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
    Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.